Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1228 ARTÍCULOS , VIENDO DEL 361 AL 375

Vascular, glial, and lymphatic immune gateways of the central nervous system

Engelhardt B, Carare RO, Bechmann I, Flügel A, Laman JD, Weller RO.

Acta Neuropathol. 2016 Sep;132(3):317-38. doi: 10.1007/s00401-016-1606-5. Epub 2016 Aug 13.

Exome sequencing in a consanguineous family clinically diagnosed with early-onset Alzheimer's disease identifies a homozygous CTSF mutation

Bras J, Djaldetti R, Alves AM, Mead S, Darwent L, Lleo A, Molinuevo JL, Blesa R, Singleton A, Hardy J, Clarimon J, Guerreiro R.

Neurobiol Aging. 2016 Oct;46:236.e1-6. doi: 10.1016/j.neurobiolaging.2016.06.018. Epub 2016 Jul 4.

Treatment strategies in Alzheimer's disease: a review with focus on selenium supplementation

Aaseth J, Alexander J, Bjørklund G, Hestad K, Dusek P, Roos PM, Alehagen U.

Biometals. 2016 Oct;29(5):827-39. doi: 10.1007/s10534-016-9959-8. Epub 2016 Aug 16.

Cigarette smoking impairs nitric oxide-mediated cerebral blood flow increase: Implications for Alzheimer's disease

Toda N, Okamura T.

J Pharmacol Sci. 2016 Aug;131(4):223-32. doi: 10.1016/j.jphs.2016.07.001. Epub 2016 Jul 16.

Editorial (Thematic Issue: Current and Perspective Therapeutic Strategies for Alzheimer's Disease)

Piccionello AP, Cappello F.

Curr Pharm Des. 2016;22(26):3935-6. doi: 10.2174/138161282226160801224800.

The Anti-Inflammatory Role of Minocycline in Alzheimer´s Disease

Budni J, Garcez ML, de Medeiros J, Cassaro E, Bellettini-Santos T, Mina F, Quevedo J.

Curr Alzheimer Res. 2016;13(12):1319-1329. doi: 10.2174/1567205013666160819124206.

Apolipoprotein E and Sex Bias in Cerebrovascular Aging of Men and Mice

Finch CE, Shams S.

Trends Neurosci. 2016 Sep;39(9):625-637. doi: 10.1016/j.tins.2016.07.002. Epub 2016 Aug 18.

Cause of Suspected Non-Alzheimer Disease Pathophysiology: If Not Tau Pathology, Then What?

Villeneuve S.

JAMA Neurol. 2016 Oct 1;73(10):1177-1179. doi: 10.1001/jamaneurol.2016.2842.

Editorial: Combining Forces to Improve Alzheimer's Disease Drug Discovery: The Symptomatic Battle

Deguil J, Auffret A, Schenker E, Aujard F, Lamberty Y, Bartrès-Faz D, Blin O, Micallef J, Richardson JC, Bordet R.

CNS Neurol Disord Drug Targets. 2016;15(7):754-5. doi: 10.2174/187152731507160808200737.

The role of navigation instruction at intersections for older drivers and those with early Alzheimer's disease

Paire-Ficout L, Marin-Lamellet C, Lafont S, Thomas-Antérion C, Laurent B.

Accid Anal Prev. 2016 Nov;96:249-254. doi: 10.1016/j.aap.2016.08.013. Epub 2016 Aug 20.

Perspectives for treating Alzheimer's disease: a review on promising pharmacological substances

Cazarim Mde S, Moriguti JC, Ogunjimi AT, Pereira LR.

Sao Paulo Med J. 2016 Jul-Aug;134(4):342-54. doi: 10.1590/1516-3180.2015.01980112.

The Role of Presenilin in Protein Trafficking and Degradation-Implications for Metal Homeostasis

Greenough MA.

J Mol Neurosci. 2016 Nov;60(3):289-297. doi: 10.1007/s12031-016-0826-4. Epub 2016 Aug 25.

Neuroprotective properties of mitochondria-targeted antioxidants of the SkQ-type

Isaev NK, Stelmashook EV, Genrikhs EE, Korshunova GA, Sumbatyan NV, Kapkaeva MR, Skulachev VP.

Rev Neurosci. 2016 Dec 1;27(8):849-855. doi: 10.1515/revneuro-2016-0036.

Impact of 2, 3, 5, 4'-tetrahydroxystilbene-2-O-β-D-glucoside on cognitive deficits in animal models of Alzheimer's disease: a systematic review

Sheng C, Peng W, Chen Z, Cao Y, Gong W, Xia ZA, Wang Y, Su N, Wang Z.

BMC Complement Altern Med. 2016 Aug 26;16(1):320. doi: 10.1186/s12906-016-1313-8.

Natural Compounds and Neuroprotection: Mechanisms of Action and Novel Delivery Systems

Bagli E, Goussia A, Moschos MM, Agnantis N, Kitsos G.

In Vivo. 2016 09-10;30(5):535-47.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias